Medical Products Support and Advanced Concept Development

Abstract

Guidance for Development of the Force (GDF) - Medical Products Support And Advanced Concept Development: funding is for product support and advanced concept development of medical products that are regulated by the US Food and Drug Administration (FDA); the accelerated transition of FDA-licensed and unregulated products and medical practice guidelines to the military operational user, through clinical and field validation studies; prototyping, risk reduction and product transition efforts for medical information technology applications; and medical training systems' technologies. The resulting advanced development portfolio is designed to address the following: areas of interest to the Secretary of Defense regarding Wounded Warriors, capabilities identified through the Joint Capabilities Integration and Development System and the strategy and initiatives described in the Quadrennial Defense Review. Program development and execution is peer-reviewed and fully coordinated with all of the Military Services, appropriate Defense Agencies or Activities and other federal agencies, to include the Department of Veterans Affairs, the Department of Health and Human Services, and the Department of Homeland Security. This coordination occurs through the planning and execution activities of the Joint Program Committees, established for the Defense Health Program Research, Development, Test and Evaluation funding. Research supported by this program element includes accelerated transition of medical training and health information sciences, to include efforts at the Pacific Based Joint Information Technology Center, advanced development of rapid pathogen detection in fresh whole blood, field assessment of intervention tools for post traumatic stress disorder (PTSD), and clinical trials on biomarkers for traumatic brain injury (TBI) and spinal cord injury, combat casualty care advanced product development and rehabilitative medicine clinical trials. The Army Medical Command received DHP Congressional Special Interest (CSI) research funding focused on Peer-Reviewed Traumatic Brain Injury and Psychological Health Research, and Peer-Reviewed Joint Warfighter Medical Research. Because of the CSI annual structure, out-year funding is not programmed.

Open PDF

Document Details

Document Type
R2 Budgetary Justification
Publication Date
Oct 01, 2014
Source ID
0604110HP_2_0130_PB_2014
Change Summary Explanation
FY 2012: Restore FY 2013 President’s Budget decrease to Congressional Special Interest from DHP RDT&E PE 0605502-Small Business Innovation Research (SBIR) Program (-$0.694 million) to DHP RDT&E, PE 0604110- Medical Products Support and Advanced Concept Development (+$0.694 million). Realignment from DHP RDT&E, PE 0604110-Medical Products Support and Advanced Concept Development (-$3.002 million) to DHP RDT&E PE 0605502-Small Business Innovation Research (SBIR) Program (+$3.002 million). Prior Approval Reprogramming (FY 12-18 PA) from DHP O&M, Budget Activity Group: Private Sector Care (-$4.000 million) to DHP RDT&E, PE 0604110-Medical Products Support and Advanced Concept Development (+$4.000 million) for Rapid Product Integration and Transition (AF). FY 2013: No Change FY 2014: No Change
Service Agency Name
Defense Health Program

Tags

DTIC Thesaurus Topics

  • Anxiety Disorders
  • Biomedical Research
  • Brain Injuries
  • Casualties
  • Clinical Trials
  • Combat Casualty Care
  • Department Of Homeland Security
  • Department Of Veterans Affairs
  • Diseases And Disorders
  • Homeland Security
  • Information Systems
  • Product Development
  • Spinal Cord
  • Spinal Injuries
  • Test And Evaluation
  • Traumatic Stress Disorder

Fields of Study

  • Medicine

Readers

  • Defense Technology Research and Development.
  • Medical or Health Care Field.
  • Military Science and Technology Research and Modernization.

Related Documents